JP2003534287A5 - - Google Patents

Download PDF

Info

Publication number
JP2003534287A5
JP2003534287A5 JP2001585794A JP2001585794A JP2003534287A5 JP 2003534287 A5 JP2003534287 A5 JP 2003534287A5 JP 2001585794 A JP2001585794 A JP 2001585794A JP 2001585794 A JP2001585794 A JP 2001585794A JP 2003534287 A5 JP2003534287 A5 JP 2003534287A5
Authority
JP
Japan
Prior art keywords
seq
composition
peptide antagonist
composition according
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001585794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003534287A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/005825 external-priority patent/WO2001089551A1/en
Publication of JP2003534287A publication Critical patent/JP2003534287A/ja
Publication of JP2003534287A5 publication Critical patent/JP2003534287A5/ja
Pending legal-status Critical Current

Links

JP2001585794A 2000-05-19 2001-03-21 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法 Pending JP2003534287A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20530500P 2000-05-19 2000-05-19
US60/205,305 2000-05-19
PCT/US2001/005825 WO2001089551A1 (en) 2000-05-19 2001-03-21 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2007302283A Division JP2008074869A (ja) 2000-05-19 2007-11-21 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法
JP2011169654A Division JP2011213742A (ja) 2000-05-19 2011-08-02 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法

Publications (2)

Publication Number Publication Date
JP2003534287A JP2003534287A (ja) 2003-11-18
JP2003534287A5 true JP2003534287A5 (enExample) 2007-12-06

Family

ID=22761653

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001585794A Pending JP2003534287A (ja) 2000-05-19 2001-03-21 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法
JP2007302283A Pending JP2008074869A (ja) 2000-05-19 2007-11-21 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法
JP2011169654A Pending JP2011213742A (ja) 2000-05-19 2011-08-02 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007302283A Pending JP2008074869A (ja) 2000-05-19 2007-11-21 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法
JP2011169654A Pending JP2011213742A (ja) 2000-05-19 2011-08-02 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法

Country Status (8)

Country Link
US (6) US7026294B2 (enExample)
EP (1) EP1282432B1 (enExample)
JP (3) JP2003534287A (enExample)
AT (1) ATE438405T1 (enExample)
AU (1) AU2001249067A1 (enExample)
CA (1) CA2409771C (enExample)
DE (1) DE60139466D1 (enExample)
WO (1) WO2001089551A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458925B1 (en) * 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
CA2409771C (en) * 2000-05-19 2008-12-02 University Of Maryland, Baltimore Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
BRPI0412430A (pt) * 2003-07-15 2006-09-05 Univ Maryland polipeptìdeo agonista do receptor de zot e zonulina
US20090176244A1 (en) * 2005-05-13 2009-07-09 Bai Julio Methods and compositions for the diagnosis of crohn's disease
TW200716159A (en) * 2005-06-09 2007-05-01 Univ Maryland Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
AU2012203787B2 (en) * 2006-02-09 2014-07-10 Alba Therapeutics Corporation Formulations for a Tight Junction Effector
AU2007215304B2 (en) * 2006-02-09 2012-06-14 Alba Therapeutics Corporation Formulations for a tight junction effector
WO2008043107A2 (en) * 2006-10-06 2008-04-10 Alba Therapeutics Corporation Use of tight junction antagonists to treat inflammatory bowel disease
WO2008052185A2 (en) 2006-10-26 2008-05-02 Alba Therapeutics Corp Materials and methods for the treatment of celiac disease
WO2008073627A2 (en) * 2006-11-03 2008-06-19 Alba Therapeutics Corporation Method of diagnosing and treating asthma
AT504214B1 (de) * 2007-01-03 2008-04-15 Bernhard Hans Peter Dipl Ing D Verfahren zur dynamischen, datenabhängigen bestimmung und anwendung von berechtigungen in hierarchischen und relationalen umgebungen
US8728491B2 (en) * 2007-05-07 2014-05-20 Alba Therapeutics Corporation Transcutaneous delivery of therapeutic agents
US20110201543A1 (en) * 2007-06-29 2011-08-18 Blake Paterson Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress
WO2009015382A2 (en) 2007-07-26 2009-01-29 Alba Therapeutics Corporation Novel peptides that enhance tight junction permeability
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
EP2062909A1 (en) 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
WO2009137436A2 (en) * 2008-05-05 2009-11-12 Alba Therapeutics Corporation Peptide conjugates
US8957032B2 (en) 2008-05-06 2015-02-17 Alba Therapeutics Corporation Inhibition of gliadin peptides
WO2018148655A1 (en) 2017-02-10 2018-08-16 Innovate Biopharmaceuticals, Inc. Compositions and methods for treating disease associated with permeability of intestinal epithelium
KR20180107341A (ko) * 2017-03-16 2018-10-02 차의과학대학교 산학협력단 칼륨 경쟁적 위산분비억제제를 유효성분을 함유하는 장 누수 증후군 치료 및 예방용 조성물
US11608359B2 (en) 2018-02-23 2023-03-21 9 Meters Biopharma, Inc. Compounds and methods for treating tight junction permeabtility
US20210069286A1 (en) * 2018-04-09 2021-03-11 9 Meters Biopharma, Inc. Compositions and methods for treating or preventing hyperglycemia, insulin resistance, and associated organ damage

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5936065A (en) * 1993-12-06 1999-08-10 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same
US6057294A (en) * 1995-01-16 2000-05-02 Northern Sydney Area Health Service Of Pacific Highway Peptide
US5665389A (en) * 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes
US7192928B1 (en) * 1996-06-11 2007-03-20 Northern Sydney & Central Coast Area Health Services T cell antigen receptor peptides
US5945510A (en) * 1997-05-21 1999-08-31 University Of Maryland, Baltimore Substantially pure zonulin, a physiological modulator of mammalian tight junctions
US6458925B1 (en) 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
CA2409771C (en) * 2000-05-19 2008-12-02 University Of Maryland, Baltimore Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
US7025294B2 (en) * 2003-05-20 2006-04-11 Carter Day International, Inc. Hammermill with stub shaft rotor apparatus and method
AU2007215304B2 (en) * 2006-02-09 2012-06-14 Alba Therapeutics Corporation Formulations for a tight junction effector
WO2008043107A2 (en) * 2006-10-06 2008-04-10 Alba Therapeutics Corporation Use of tight junction antagonists to treat inflammatory bowel disease
WO2008052185A2 (en) * 2006-10-26 2008-05-02 Alba Therapeutics Corp Materials and methods for the treatment of celiac disease

Similar Documents

Publication Publication Date Title
JP2003534287A5 (enExample)
CN102292346B (zh) 肥胖的治疗
JP2005516885A5 (enExample)
Nishi et al. The soybean β-conglycinin β 51–63 fragment suppresses appetite by stimulating cholecystokinin release in rats
TWI221845B (en) Peptide analogues
SK82096A3 (en) Compounds influencing growth hormone releasing
JPH11507637A (ja) 食欲調節組成物
WO1995000161A1 (en) Neuropeptide y antagonists and agonists
JP2005524648A5 (enExample)
JP5000663B2 (ja) 神経ペプチド２受容体アゴニスト
JP2004520395A5 (enExample)
JP2012500847A5 (enExample)
JP2003535043A5 (enExample)
JP2003501068A5 (enExample)
PL181286B1 (pl) Zwiazki o wlasciwosciach uwalniania hormonu wzrostu i zawierajace je kompozycje farmaceutyczne PL PL PL PL PL PL PL PL
WO2004019872A3 (en) Oral delivery of modified transferrin fusion proteins
JPH06503090A (ja) ノナペプチドのボンベシン拮抗薬
JP2006506942A5 (enExample)
JP2005508338A5 (enExample)
JP2004521123A5 (enExample)
CA2952475A1 (en) Vip fragment for the treatment of myocardial fibrosis
JP2022514241A (ja) ミトコンドリア病を標的とするアナログ
DK164109B (da) Lh-rh-antagonister og deres farmaceutisk acceptable syreadditionssalte og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
WO1995003818A1 (en) Powder for nasal administration of peptidic or proteinaceous drug
JP2004536834A5 (enExample)